Unity Biotechnology, Inc. (UBX) Social Stream
UNITY BIOTECHNOLOGY INC (UBX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering UBX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-05 | 6 | $12 | $4 | $7.8 | $2.45 | 218.37% |
| 2021-11-12 | 6 | $12 | $4 | $7.666 | $2.45 | 212.9% |
| 2021-12-15 | 7 | $12 | $4 | $7.142 | $2.45 | 191.51% |
| 2022-05-12 | 7 | $12 | $4 | $7.142 | $2.45 | 191.51% |
| 2022-05-17 | 5 | $12 | $3 | $6.857 | $2.45 | 179.88% |
| 2022-08-15 | 6 | $12 | $3 | $6.857 | $2.45 | 179.88% |
| 2022-08-16 | 6 | $12 | $3 | $7.428 | $2.45 | 203.18% |
| 2022-10-13 | 6 | $120 | $30 | $78.333 | $2.45 | 3097.27% |
| 2022-10-20 | 6 | $120 | $11 | $75.166 | $2.45 | 2968% |
| 2022-11-02 | 6 | $120 | $11 | $74.5 | $2.45 | 2940.82% |
| 2022-11-10 | 6 | $120 | $10 | $56 | $2.45 | 2185.71% |
| 2022-11-11 | 6 | $80 | $10 | $38 | $2.45 | 1451.02% |
| 2022-11-16 | 6 | $80 | $10 | $26.666 | $2.45 | 988.41% |
| 2023-03-20 | 5 | $80 | $10 | $29.8 | $2.45 | 1116.33% |
| 2023-04-05 | 5 | $12 | $5 | $7.6 | $2.45 | 210.2% |
| 2023-05-15 | 5 | $12 | $3 | $7.2 | $2.45 | 193.88% |
| 2023-05-26 | 5 | $12 | $3 | $7.4 | $2.45 | 202.04% |
| 2023-05-31 | 6 | $12 | $3 | $7.833 | $2.45 | 219.71% |
| 2023-06-26 | 6 | $10 | $2 | $6.8 | $2.45 | 177.55% |
| 2023-07-10 | 6 | $12.001 | $2 | $7.666 | $2.45 | 212.9% |
| 2023-08-11 | 6 | $12 | $2 | $7.666 | $2.45 | 212.9% |
| 2023-08-31 | 6 | $10 | $2 | $7.333 | $2.45 | 199.31% |
The Trend in the Analyst Price Target
Over the past 41 weeks, UBX's average price target has gone down $22.47.
UBX reports an average of 1,322.53% for its upside potential over the past 46 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-13 | 6 | 12 | 3 | 7.833 | 0.405 | 1834.07% |
| 2022-10-13 | 6 | 120 | 30 | 78.333 | 0.405 | 19241.48% |
| 2022-11-10 | 6 | 120 | 10 | 56.000 | 2.120 | 2541.51% |
| 2023-06-26 | 6 | 10 | 2 | 6.800 | 3.110 | 118.65% |
| 2023-08-11 | 6 | 12 | 2 | 7.666 | 2.600 | 194.85% |
UBX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 42 months, UBX's average broker recommendation rating improved by 0.17.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- UNITY BIOTECHNOLOGY INC's variance in analysts' estimates is lower than -2418.73% of all US stocks.
- In the context of all US stocks, UNITY BIOTECHNOLOGY INC's upside potential (average analyst target price relative to current price) is higher than 2391.92% of them.
- UBX has a greater average analyst price target than 546.43% of all US stocks.
- In terms of how UNITY BIOTECHNOLOGY INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 1908.23% of that group.
Stocks similar to UNITY BIOTECHNOLOGY INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are FIXX, BTAI, and MBIO.
View All Top Stocks by Price Target
Make investment decisions regarding UBX using the data that counts. Try POWR Ratings for free.